| Exchange: |
NGM |
| Last Open: |
11.43 |
| Day Range: |
11.10 - 11.45 |
| Last Close: |
11.28 |
| Change: |
-0.09 (N/A) |
| Volume: |
483,279 |
| Avg Vol (3m): |
684,213 |
| 52wk Range: |
5.54 - 11.62 |
| Market Cap: |
1,164,000,000 |
| EBITDA: |
N/A |
| Revenue: |
57,200,000 |
Address:
Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego, CA 92121
United States
Web Site:
|
(HALO) DIVIDEND RATINGS:
| Overall Rating: |
|
| The overall rating is a weighted average of the three other rated categories listed below. It is a general indication of the health of a dividend. Rating last changed:
Never |
|
| Dividend Yield: |
|
| This indicator measures a stock's current dividend yield, and compares it to similar stocks and historical yields. |
| Dividend History: |
|
| The rating for dividend history is determined by looking back at the frequency and amount of historical dividend payments. |
| Div. Increases: |
|
| This indicator measures a stock's history of dividend increases; consistent increases over time will produce a favorable rating.
|
|
HEADLINES FOR (HALO):
OTHER BIOTECHNOLOGY COMPANIES:
Amgen Inc. (AMGN)
Celgene Corporation (CELG)
Gilead Sciences Inc. (GILD)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
SEE FULL LIST
|
